日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model

乳腺癌模型中对雌激素和 HER 激活生长的附带抵抗与 AKT、ERα 和细胞周期信号的改变有关

Kate M Moore #, Vera Cerqueira #, Kenneth G MacLeod #, Peter Mullen, Richard L Hayward, Simon Green, David J Harrison, David A Cameron, Simon P Langdon

Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus

针对口蹄疫病毒开发的整合素 αvβ6 特异性胰腺癌疗法

Kate M Moore, Ami Desai, Bea de Luxán Delgado, Sara Maria David Trabulo, Claire Reader, Nicholas F Brown, Elizabeth R Murray, Adam Brentnall, Philip Howard, Luke Masterson, Francesca Zammarchi, John A Hartley, Patrick H van Berkel, John F Marshall

The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy

整合素 αvβ6 通过多种机制驱动胰腺癌,是治疗的有效靶点

Claire S Reader, Sabari Vallath, Colin W Steele, Syed Haider, Adam Brentnall, Ami Desai, Kate M Moore, Nigel B Jamieson, David Chang, Peter Bailey, Aldo Scarpa, Rita Lawlor, Claude Chelala, Stephen M Keyse, Andrew Biankin, Jennifer P Morton, Tr Jeffry Evans, Simon T Barry, Owen J Sansom, Hemant M Ko

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

PHLDA1介导受体酪氨酸激酶驱动的癌症的耐药性

Abbie E Fearon, Edward P Carter, Natasha S Clayton, Edmund H Wilkes, Ann-Marie Baker, Ekaterina Kapitonova, Bakhouche A Bakhouche, Yasmine Tanner, Jun Wang, Emanuela Gadaleta, Claude Chelala, Kate M Moore, John F Marshall, Juliette Chupin, Peter Schmid, J Louise Jones, Michelle Lockley, Pedro R Cuti